Year: 2013
Type: article
Abstract: Hepcidin is a key hormone that is involved in the control of iron homeostasis in the body. Physiologically, hepcidin is controlled by iron stores, inflammation, hypoxia, and erythropoiesis. The regulation of hepcidin expression by iron is a complex process that requires the coordination of multiple proteins, including hemojuvelin, bone morphogenetic protein 6 (BMP6), hereditary hemochromatosis protein, transferrin receptor 2, matriptase-2, neogenin, BMP receptors, and transferrin. Misregulation of hepcidin is found in many disease states, such as the anemia of chronic disease, iron refractory iron deficiency anemia, cancer, hereditary hemochromatosis, and ineffective erythropoiesis, such as β-thalassemia. Thus, the regulation of hepcidin is the subject of interest for the amelioration of the detrimental effects of either iron deficiency or overload.
DOI: 10.1172/jci67225
Institution: Oregon Health & Science University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: hepcidin, iron homeostasis, iron regulation, hemojuvelin, BMP6, transferrin receptor 2, matriptase-2, neogenin, BMP receptors, transferrin, inflammation, hypoxia, erythropoiesis, anemia of chronic disease, iron-refractory iron deficiency anemia, hereditary hemochromatosis, beta-thalassemia, iron deficiency, iron overload
Open Access status: bronze
OpenAlex ID: W1979134200
